Thinking Zinc: a Study of Zinc Supplements on the Navajo Nation

Part of paid clinical trials in Albuquerque, New Mexico.

Sponsor
University of New Mexico
Study ID
NCT03908736
Phase
PHASE2
Status
Recruiting
Apply to this trial

Conditions

  • DNA Damage
  • Immune System Disorder

Eligibility Criteria

Sex
ALL
Age
21 Years - 64 Years
Healthy Volunteers
Accepted

Interventions

  • Zinc Picolinate 15 Mg — DRUG
    zinc picolinate, 15 mg/day for 6 months

Study Details

This is a study to assess the effect of dietary zinc supplementation to mitigate biomarkers of metal toxicity in exposed tribal populations.

Key Dates

Start date
May 19, 2019
Status verified
Jun 2026
Primary completion
Jul 31, 2027
Completion
Dec 31, 2027

Study Design

Enrollment
100 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE

Arms

  • Other: Single-arm cohort
    Baseline experimental measurements will be collected for each individual participant twice prior to zinc supplementation (0 month and 3 month time points). After zinc supplementation, experimental measurements will be collected for each individual participant at the 6 month and 9 month time points. The zinc intervention is zinc picolinate 15 mg once per day for 6 months.

Primary Outcome Measure

Metal biomonitoring to compare change from baseline versus zinc supplement [ Time Frame: Visit 1 (0 months-baseline 1), Visit 2 (3 months-baseline 2), Visit 3 (6 months-zinc 1), Visit 4 (9 months-zinc 2) ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of New Mexico Health Sciences CenterAlbuquerqueNew Mexico87131
Laurie G Hudson, PhD
[email protected]
505-272-2482
Debra MacKenzie, PhD
[email protected]
505-272-6535

Find similar trials in Albuquerque, NM

By research site
University of New Mexico Health Sciences Center· Albuquerque, NM

Related Studies